ReviewInteractive cardiovascular and thoracic surgery2022
Impella support as a bridge to heart surgery in patients with cardiogenic shock.
Review in Interactive cardiovascular and thoracic surgery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed.
- Impact of mechanical support with the impella for ventricular septal rupture.General thoracic and cardiovascular surgery · 2026Article
- Coronary Artery Bypass Grafting Under ECPELLA Support After Out-of-Hospital Cardiac Arrest: A Case Report.Clinical case reports · 2026Article
- Unexpected rupture of the left ventricular wall following surgical repair of post-infarction ventricular septal rupture in a patient supported by Impella CP: a case report.European heart journal. Case reports · 2026Article
- Technical considerations for surgical explantation of microaxial, catheter-based percutaneous ventricular assist device via the ascending aorta.JTCVS techniques · 2025Article
- Contemporary optimal therapeutic strategy with escalation/de-escalation of temporary mechanical circulatory support in patients with cardiogenic shock and advanced heart failure in Japan.Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs · 2025Review
- Article
- A Case of the Utility of Viscoelastic Testing for the Management of the Impella Device in Heparin Anticoagulation.Cureus · 2025Article
- The role of Impella in the pre-procedural management of post-infarct ventricular septal defect: a systematic review.Interdisciplinary cardiovascular and thoracic surgery · 2024Article
- Temporary microaxial transvalvular left ventricular assist device for post-myocardial infarction ventricular septal rupture: Bridging a paradigm shift.JTCVS techniques · 2024Article
- The use of perioperative Impella 5.5 support in high-risk cardiac surgery: a retrospective cohort study.Journal of thoracic disease · 2024Article
- A patient with extensive ST elevation myocardial infarction who underwent emergent Impella CP® assisted off-pump coronary artery bypass without mechanical complication.Journal of cardiology cases · 2024Article
- Modelling and Simulation of the Combined Use of IABP and Impella as a Rescue Procedure in Cardiogenic Shock: An Alternative for Non-Transplant Centres?Bioengineering (Basel, Switzerland) · 2023Article
- Association of timing of percutaneous left ventricular assist device insertion with outcomes in patients undergoing cardiac surgery.JTCVS open · 2023Article
- Multidisciplinary treatment for infective endocarditis complicated with systemic multiple abscess due to Panton-Valentine leukocidin producing community-acquired methicillin-resistant Staphylococcus aureus and Candida albicans: a case report.General thoracic and cardiovascular surgery cases · 2023Article
- Single center experience and early outcomes of Impella 5.5.Frontiers in cardiovascular medicine · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesIn patients with cardiogenic shock, delayed surgery after stabilization of haemodynamics and improvement in end-organ function by mechanical circulatory support is known to yield better outcomes than emergency surgery. We aimed to investigate the effectiveness of Impella (Abiomed, Danvers, MA, USA) as a bridge to cardiac surgery in patients with cardiogenic shock.
methodsWe reviewed 7 patients with cardiogenic shock who underwent Impella support as a bridge to cardiac surgery using cardiopulmonary bypass at our institution between April 2018 and August 2021.
resultsCardiogenic shock was caused by ventricular septal rupture in 3 patients, papillary muscle rupture in 1 and acute myocardial infarction in 3. Cardiac surgery was delayed by 1-7 (3.9 ± 2.5) days with Impella support after the diagnosis of cardiogenic shock, during which the hepatic and renal function of the patients improved significantly. Device-related or operation-related adverse events included re-exploration for bleeding in 3 patients, acute limb ischaemia due to thromboembolism in 1 and intraoperative aortic dissection in 1. Thirty-day mortality was 14.3%, and the cumulative survival was 71.4% at 1 year. The survival tended to be better than that in historical control group in which extracorporeal membrane oxygenation was used as a bridge to surgery (P = 0.0992).
conclusionsImpella is an effective tool for bridging patients with cardiogenic shock to surgery. This strategy may improve surgical outcomes in patients with cardiogenic shock. However, prolonged Impella support may increase significant adverse events, and further investigation is required to determine the optimal duration of support before surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.